BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22718818)

  • 21. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
    Zhu W; Wu C; Deng W; Pei R; Wang Y; Cao L; Qin B; Lu M; Chen X
    PLoS One; 2012; 7(9):e45146. PubMed ID: 23024803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models.
    Kosinska AD; Pishraft-Sabet L; Wu W; Fang Z; Lenart M; Chen J; Dietze KK; Wang C; Kemper T; Lin Y; Yeh SH; Liu J; Dittmer U; Yuan Z; Roggendorf M; Lu M
    Hepatology; 2017 Jul; 66(1):69-83. PubMed ID: 28295453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
    Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model.
    Bourgine M; Dion S; Godon O; Guillen G; Michel ML; Aguilar JC
    Virology; 2012 Aug; 430(1):10-9. PubMed ID: 22591777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The woodchuck: a model for therapeutic vaccination against hepadnaviral infection.
    Roggendorf M; Yang D; Lu M
    Pathol Biol (Paris); 2010 Aug; 58(4):308-14. PubMed ID: 20646874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Woodchuck Hepatitis Virus (WHV) transgene mouse models show sex-dependent WHV replicative activity and development of spontaneous immune responses to WHV proteins.
    Meng Z; Ma Z; Zhang E; Kosinska AD; Liu J; Zhang X; Zhou T; Wu J; Dahmen U; Dirsch O; Yang D; Roggendorf M; Lu M
    J Virol; 2014 Feb; 88(3):1573-81. PubMed ID: 24257601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Common linear B-cell epitopes in human hepatitis B virus core protein and woodchuck hepatitis virus core protein].
    Zhang ZH; Wang R; Tian YJ; Li L; Xia JB; Gong JS; Lu MJ; Gong FL; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):605-8. PubMed ID: 17711632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.
    Su J; Brunner L; Ates Oz E; Sacherl J; Frank G; Kerth HA; Thiele F; Wiegand M; Mogler C; Aguilar JC; Knolle PA; Collin N; Kosinska AD; Protzer U
    J Hepatol; 2023 Apr; 78(4):717-730. PubMed ID: 36634821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens.
    Luxembourg A; Hannaman D; Wills K; Bernard R; Tennant BC; Menne S; Cote PJ
    Vaccine; 2008 Jul; 26(32):4025-33. PubMed ID: 18556096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen.
    Zhang W; Dong SF; Sun SH; Wang Y; Li GD; Qu D
    World J Gastroenterol; 2006 Aug; 12(29):4727-35. PubMed ID: 16937447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.
    Roggendorf M; Kosinska AD; Liu J; Lu M
    Cold Spring Harb Perspect Med; 2015 Oct; 5(12):. PubMed ID: 26511761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
    Li X; Yang X; Jiang Y; Liu J
    Int Immunol; 2005 Oct; 17(10):1293-302. PubMed ID: 16113237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
    Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
    Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice.
    Backes S; Jäger C; Dembek CJ; Kosinska AD; Bauer T; Stephan AS; Dišlers A; Mutwiri G; Busch DH; Babiuk LA; Gasteiger G; Protzer U
    Vaccine; 2016 Feb; 34(7):923-32. PubMed ID: 26776470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge.
    Menne S; Maschke J; Lu M; Grosse-Wilde H; Roggendorf M
    J Virol; 1998 Jul; 72(7):6083-91. PubMed ID: 9621072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
    Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
    Chow YH; Huang WL; Chi WK; Chu YD; Tao MH
    J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
    Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg].
    Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B
    Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal route favors the induction of CD4
    Bourgine M; Crabe S; Lobaina Y; Guillen G; Aguilar JC; Michel ML
    Antiviral Res; 2018 May; 153():23-32. PubMed ID: 29510155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.